Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
J Proteome Res ; 8(11): 5175-87, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19821561

ABSTRACT

The amino sugar galactosamine (galN) induces alterations in the hepatic uridine nucleotide pool and has been widely used as a model of human viral hepatitis. Histopathological and clinical chemistry analyses of a cohort of rats following administration of galN revealed extreme interindividual variability in the extent of the toxic response which enabled classification of 'responder' and 'non-responder' phenotypes. An integrative metabolic profiling approach was applied to characterize biomarkers of exposure to galN in urine, serum, feces and liver from responders and non-responders. The presence of N-acetylglucosamine and galN in the urine correlated with the occurrence and extent of toxic response. Conversely, the novel identification of galN-pyrazines in the feces of non-responders and their virtual absence in the feces of responders suggests an alternative means of distribution and metabolism of galN in non-responders. The absence of the UDP-hexosamines in the liver of non-responders further supports differential metabolism of galN and suggests an ability of non-responders to avoid UDP-glucose depletion. An observed disturbance of gut microbial derived metabolites in the urine and feces of non-responders may suggest a role of the microflora in reducing the effective dose of galN. This systems level metabonomic approach has provided new mechanistic insights into differential response to galN and is widely applicable to the study of interindividual variation in metabolism for any xenobiotic intervention.


Subject(s)
Biomarkers/metabolism , Chemical and Drug Induced Liver Injury/metabolism , Galactosamine , Animals , Biomarkers/chemistry , Chemical and Drug Induced Liver Injury/pathology , Feces/chemistry , Galactosamine/metabolism , Galactosamine/toxicity , Humans , Liver/chemistry , Liver/metabolism , Liver/pathology , Male , Molecular Structure , Nuclear Magnetic Resonance, Biomolecular , Phenotype , Rats , Rats, Sprague-Dawley , Urine/chemistry
2.
Magn Reson Chem ; 47 Suppl 1: S47-53, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19856339

ABSTRACT

High-resolution (1)H magic angle spinning (MAS) NMR spectroscopy is a useful tool for analysing intact tissues as a component of metabonomic studies. The effect of referencing MAS NMR spectra to the chemical shifts of glucose or to that or trimethylsilylpropionic acid on the resultant multivariate statistical models have been investigated. It is shown that referencing to known chemical shifts of either alpha-glucose or beta-glucose in (1)H MAS NMR-based metabolic data of intact liver tissues is preferred. This has been exemplified in studies of galactosamine toxicity in the rat where co-administration of glycine ameliorates the toxic response. This approach leads to better aligned sets of spectra and reduces the inter-sample variability in multivariate statistical models. If glucose is not present in the tissue under study, then a number of alternative internal reference chemical shifts are presented. Finally, the chemical shift difference between that of the anomeric H1 proton of alpha-glucose and residual water is confirmed as a suitable internal temperature calibration method.


Subject(s)
Galactosamine/toxicity , Glycine/pharmacology , Liver/pathology , Metabolomics , Animals , Liver/drug effects , Magnetic Resonance Spectroscopy , Male , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL